Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEAD: Fasudil for Early Alzheimer's Disease
NCT06362707Phase 2Recruiting
- Sponsor
- Stavanger University Hospital
- Start
- Aug 2024
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fasudil in Alzheimer's disease (AD), sponsored by Stavanger University Hospital. Started Aug 2024; status: recruiting.
02
Drugs
fasudil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06362707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06362707.